Abstract
Detecting inflammation is among the most important aims of medical imaging. Inflammatory process involves immune system activity and local tissue response. The role of PET with fludeoxyglucose F 18 has been expanded. Systemic vasculitides and cardiopulmonary inflammatory disorders constitute a wide range of diseases with multisystemic manifestations. PET with fludeoxyglucose F 18 is useful in their diagnosis, assessment, and follow-up. This article provides an overview of the current status and potentials of hybrid molecular imaging in evaluating cardiopulmonary and vascular inflammatory diseases focusing on the potential for PET with fludeoxyglucose F 18/MR imaging and PET/CT scans.
Original language | English (US) |
---|---|
Pages (from-to) | 559-576 |
Number of pages | 18 |
Journal | PET Clinics |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2020 |
Externally published | Yes |
Keywords
- Cardiopulmonary inflammation
- MRI
- PET
- PET/CT
- PET/MR
- Vasculitis
ASJC Scopus subject areas
- Radiation
- Radiology Nuclear Medicine and imaging